- Eat Just halts operations in Singapore amid lawsuit, production challenges.
- Plans for largest plant-protein factory put on hold.
- Investors like C2 Capital face setbacks in alternative proteins industry.
Eat Just halts operations in Singapore
US-based Eat Just, known for its plant-based egg substitute Just Egg and cultivated meat brand Good Meat, has reportedly suspended operations in Singapore, according to The Straits Times.
This development comes in the wake of a US$100 million lawsuit from its bioreactor manufacturer in the US, as reported in late 2023.
Eat Just cited the need to evaluate processing conditions, unit economics, and strategic approaches to production in Asia as reasons behind the suspension.
Eat Just’s ambitious growth plans
While Eat Just has not disclosed a timeline for resuming operations, the company has expressed intentions to double its production quantity in Singapore this year compared to previous years.
Plans for building the largest plant-protein factory in Singapore’s Pioneer area, funded by a US$120 million investment from Eat Just and Proterra Investment Partners Asia, have been put on hold, affecting initiatives such as Just Egg’s expansion.
.jpg)
C2 Capital Partners support
These setbacks highlight the challenges faced by companies in the alternative proteins industry, where significant investments are required due to the higher costs associated with cell-based meat production compared to traditional methods.
Eat Just’s presence in Singapore, which began in 2020 after securing local approval, is backed by investors such as Alibaba-backed private equity firm C2 Capital Partners.
To read the original article in its entirety: https://www.techinasia.com/eat-walks-egg-shells-company-halts-operations-singapore-report
